AlphaFold predicted structure
MOGS · Q13724

Mean pLDDT
91.9/ 100
Very high
837 residues
Confidence breakdown
- Very high(≥ 90)84%
- Confident(70–90)8%
- Low(50–70)3%
- Very low(< 50)5%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
mannosyl-oligosaccharide glucosidase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Congenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalCOVID-19 research
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomal+2 more panels — install the extension to see the full list inline on any page.
MOGS-congenital disorder of glycosylation
congenital disorder of glycosylation
congenital disorder of glycosylation type II
COVID-19
SRD5A3-congenital disorder of glycosylation
severe acute respiratory syndrome
hereditary disease
colorectal carcinoma
epidermolysis bullosa simplex 2E, with migratory circinate erythema
Epidermolysis bullosa simplex with circinate migratory erythema
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Mannosyl-oligosaccharide glucosidase
In the context of N-glycan degradation, cleaves the distal alpha 1,2-linked glucose residue from the Glc(3)Man(9)GlcNAc(2) oligosaccharide precursor in a highly specific manner
MOGS · Q13724

Mean pLDDT
91.9/ 100
Very high
837 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0